Methylisopropyltryptamine

Methylisopropyltryptamine
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
Identifiers
IUPAC name
  • N-[2-(1H-indol-3-yl)ethyl]-N-methylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC14H20N2
Molar mass216.328 g·mol−1
3D model (JSmol)
SMILES
  • CC(C)N(C)CCc1c[nH]c2ccccc12
InChI
  • InChI=1S/C14H20N2/c1-11(2)16(3)9-8-12-10-15-14-7-5-4-6-13(12)14/h4-7,10-11,15H,8-9H2,1-3H3 checkY
  • Key:KTQJVAJLJZIKKD-UHFFFAOYSA-N checkY
  (verify)

N-Methyl-N-isopropyltryptamine (MiPT) is a psychedelic tryptamine, closely related to DMT, DiPT and Miprocin.

Chemistry

MiPT base, unlike many other tryptamines in their freebase form, does not decompose rapidly in the presence of light or oxygen.

In August 2019, Chadeayne et al. solved the crystal structure of MiPT fumarate.[1] Its systematic name is [2-(1H-indol-3-yl)ethyl](methyl)propan-2-ylazanium 3-carboxyprop-2-enoate. The salt consists of a protonated tryptammonium cation and a 3-carboxyacrylate (hydrogen fumarate) anion in the asymmetric unit.

Dosage

10-25 mg is usually taken orally, with effects lasting 4–6 hours.

Effects

MiPT is said to emphasize psychedelic/entheogenic effects over sensory/hallucinogenic activity. Users report strong mental effects, but few perceptual alterations.

Hyper sensitivity to sound as well

Legality

Sweden's public health agency suggested classifying MiPT as a hazardous substance, on May 15, 2019.[2]

MiPT is unscheduled in the United States. It may be considered controlled as an analog of another stimulant, alpha-methyl-tryptamine, but this has not been tested in court.

See also

References

  1. ↑ Chadeayne AR, Pham DN, Golen JA, Manke DR (September 2019). "N-methyl derivatives of DMT and psilocin". Acta Crystallographica Section E. 75 (Pt 9): 1316–1320. doi:10.1107/S2056989019011253. PMC 6727059. PMID 31523457.
  2. ↑ "Folkhälsomyndigheten föreslår att 20 ämnen klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 15 May 2019.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.